Angela Dotson

Vasorum USA, Inc., a US subsidiary of Vasorum Ltd., presents Celt ACD®, a single use femoral artery puncture closure device for safe and effective closure of 5F - 7F punctures. With over 100,000 patient implants to date, Celt ACD has proven itself to be a best-in-class arterial puncture closure device.

Enabling Structural Heart, Electrophysiology, and Heart Failure Procedures

AventaMed is an emerging medical device company focused on simplifying surgical procedures and reducing costs for healthcare providers. AventaMed has developed a novel medical device which allows grommets to be placed safely and quickly in an office setting, eliminating the need for general anaesthetic and costly OR time. 7% of all children have grommets (2 million / year), making it a large market, worth over $5.4 billion worldwide.

2MG Inc. is a pharmaceutical organization based and operating in the Philippines. 2MG Inc. is engaged in the marketing and distribution of pharmaceutical products acquired through licensing and supply agreements with many international companies. 2MG Inc. is a Philippine-based pharmaceutical distributor engaged in the business of importation, registration, distribution, and marketing of Anti-Infective, Pulmo, oncology & other therapeutic products across the Philippines.

Levee Medical, Inc. designs, develops, and manufactures innovative urological devices with the focus of improving recovery outcomes post-prostatectomy so that patients can quickly and confidently return to normal activity. The company’s inaugural product is designed to support and stabilize the post-operative bladder neck and urethra following prostatectomy to accelerate the return of continence and reduce the overall risk of chronic incontinence.

http://www.altascience.ie

Vasorum USA, Inc., a US subsidiary of Vasorum Ltd., presents Celt ACD®, a single use femoral artery puncture closure device for safe and effective closure of 5F - 7F punctures. With over 100,000 patient implants to date, Celt ACD has proven itself to be a best-in-class arterial puncture closure device.

Enabling Structural Heart, Electrophysiology, and Heart Failure Procedures

Cardio Flow, Inc. is an innovative medical device company that is developing a modern platform and portfolio of orbital atherectomy products that enable Physicians to treat patients suffering from PAD.

Saranas has developed a technology that allows for the early detection and monitoring of bleeding complications associated with vascular access procedures. The Early Bird Bleed Monitoring System includes a vascular access sheath with embedded sensors that measure the electrical resistance across the blood vessel. By sensing a change in the vessel’s electrical resistance, the Early Bird is designed to detect and monitor bleeding from a blood vessel accidentally injured during endovascular procedures, such as transcatheter aortic valve replacement, large bore hemodynamic support device placement, or other complex cardiac interventions, where the femoral artery or vein is used to gain vascular access to the heart. The technology was invented at the Texas Heart Institute.